UCSF Radiology and Biomedical Imaging to be Key Contributor to IDEAS Study

Photo courtesy of IDEAS Study

We are proud to be a site for the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study. This $100 million study will be the largest of its kind, eventually enrolling over 18,000 patients to assess the clinical utility of amyloid PET scans for guiding medical management and improving outcomes in patients suffering from cognitive impairment of uncertain cause.

The study was developed by the IDEAS study group, led by Gil Rabinovici, MD, associate professor in the UCSF Department of Neurology; Maria Carrillo, PhD, chief science officer of the Alzheimer's Association, and other partners. The IDEAS Study is led by the Alzheimer's Association and the American College of Radiology Imaging Network (ACRIN) and managed by the American College of Radiology (ACR.)

The UCSF Memory & Aging Center is an internationally recognized leader in the clinical and research assessment of a broad scope of dementing illnesses, including Alzheimer’s disease. Physicians interested in referring their eligible patients for a comprehensive, multi-disciplinary neurocognitive assessment to the IDEAS study should contact the UCSF Memory and Aging Center at (415) 353-2057. Neurologists, gerontologists, and psychiatrists participating in the IDEAS Study can refer directly to the Department of Radiology by contacting the Department of Radiology Scheduling at (415) 353-3900.

To learn more about the IDEAS Study, please click here